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Abstract Mercury (Hg2+), a sulfhydryl group reactant, was 
used to probe structure-function relationships in photosystem II
(PSII). In the present work, we investigated the impact of mer- 
cury on the polypeptide composition of PSII submembrane prep- 
arations. Electrophoretic analysis revealed that the incubation of 
the membranes in the presence of mercury produces the depletion 
of a polypeptide of molecular weight of 33 kDa. This polypeptide 
corresponds to the extrinsic protein EP33 of the oxygen evolving 
complex removed following urea treatment. However, the two 
closely related extrinsic polypeptides of 16 and 23 kDa, usually 
removed concomitantly after urea treatment, remained unaf- 
fected after the mercury treatment. These data demonstrated the 
existence of an intrinsic binding site for EP23. The molecular 
mode of action of mercury in the oxygen evolving complex of 
PSII is discussed. 
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1. Introduction 
Photosystem II is the thylakoid membrane bound complex 
where the unique process of water oxidation takes place. 
Among the constituents of this supramolecular complex, three 
extrinsic polypeptides (EP) of 16, 23, and 33 kDa respectively, 
and two inorganic ofactors, chloride and calcium, are thought 
to play structural and regulatory roles in the process (for a 
review see [1]). Their structural and functional organization are 
still under current investigation and the use of specific inhib- 
itors constitutes a valuable approach to elucidate this question. 
In a recent study [2], we have demonstrated that mercury 
treatment of PSII submembrane fractions leads to a strong 
inhibition of oxygen evolution. Furthermore, this inhibition 
could be prevented by the addition of moderate concentrations 
(10 mM) of chloride, an essential cofactor of PSII. It is known 
that removal of EP 16, 23, and 33 leads to the inhibition of 
oxygen evolution and that the activity could be recovered, at 
least partially, by the addition of chloride and/or calcium cofac- 
tors [3,4]. Considering these observations, it is of interest o 
study the impact of mercury treatment on the polypeptide com- 
position of the PSII submembrane fractions to verify if this 
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metal ion exerts some action on the release of the extrinsic 
polypeptides. Electrophoresis analysis revealed that the EP33 
was removed in the presence of mercury, but not the closely 
related polypeptides of 16 and 23 kDa. This result discloses new 
information on the structural organization of PSII. 
2. Materials and methods 
PSII submembrane fractions were isolated from barley (Hordeum 
vulgarae) according to [5] and from spinach (Spinacia oleracea L.) 
according to [6] with the modifications described previously [7]. The 
PSII preparations were finally resuspended in 400 mM sucrose and 20 
mM MES-TMAOH pH 6.3 and were stored in liquid nitrogen until use. 
In one case, EP33, EP23 and EP16 were removed by urea treatment 
according to Myao and Murata [8] or EP23 and EP16 were removed 
by 1 M NaC1 treatment as described by Nakatani [9]. 
Mercury treatment (5-min incubation) was performed in the dark, at 
22°C as described previously [2]. The assay media contained: 400 mM 
sucrose, 20 mM MES-NaOH (pH 6.3), 15 pg Chl/ml and the indicated 
concentrations of HgCI2. To determine the polypeptide(s) released by 
mercury, the PSII preparations were harvested immediately after treat- 
ment by a 8-min centrifugation in an Eppendorf microcentrifuge. The 
pellets were washed once in 400 mM sucrose, 20 mM MES-NaOH (pH 
6.3) and were used for polypeptide analysis. The first supernatants were 
further centrifuged (40 min) to remove remaining membrane fragments. 
The supernatant was then concentrated against a sucrose gradient and 
dialysed against the above buffer before analysis by polyacrylamide g l 
electrophoresis. The latter was performed at room temperature in the 
buffer system of Laemmli [10] using miniature slab gels (Hoefer Scien- 
tific Instruments) containing 15% acrylamide. The gels were stained 
with Coomassie brilliant blue and scanned with an LKB Ultro Scan XL 
laser densitometer. The polypeptide content of each band was evaluated 
by integration of the peaks and the lines were normalized with each 
other using the intensity of the band of a polypeptide that is not 
influenced by mercury. 
Oxygen evolution was measured at 22°C, using a Clark type oxygen 
electrode [11]. The assay medium contained 400 mM sucrose, 20 mM 
MES-TMAOH, 0.35 mM DCBQ as PSII electron acceptor, 15 ¢tg 
Chl/ml and the mentioned concentrations of mercury. In the absence 
of mercury, the oxygen evolution rate in the barley preparations u ed 
was 395 + 10 ¢tmol OJmg Chl.h. 
3. Results 
The polypeptide profile of PSII submembrane fractions after 
various treatments is shown in Fig. 1. In lane 3, it is shown that 
a 30-min incubation of the PSII submembrane fragments in the 
presence of 10/.tM HgC12 produces a 40% depletion of a pol- 
ypeptide of molecular weight of 33 kDa compared to the con- 
trol (lane 2). The 33 kDa polypeptide was recovered in the 
supernatant of the treated samples as can be seen in lane 4; no 
other polypeptides were found in the supernatant. In lane 6, the 
polypeptide profile following urea treatment is presented. This 
treatment is known to remove EP16, EP23 and EP33 of the 
oxygen evolving complex. The 33 kDa protein removed follow- 
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Fig. 1. Gel electrophoresis pattern of various PSII preparations illus- 
trating the depletion of EP33 by Hg 2+. Lane 1, molecular weight 
standards for phosphorylase B, bovine serum albumin, ovalbumin, 
carbonic anhydrase, soybean trypsin inhibitor a d lysozyme. Lane 2, 
control PSII; lane 3, HgCl:-treated PSII; lane 4, supernatant of HgC12- 
treated PSII; lane 5, supernatant of urea-treated PSII; lane 6, urea- 
treated PSII. Numbers on the left and right side indicate apparent 
molecular masses (kDa) of proteins in resolved bands. For conditions, 
see section 2. 
ing mercury treatment (lane 4) corresponds to EP33 removed 
following urea treatment as shown in lane 5 corresponding to 
the supernatant. However, we can see that the 16 and 23 kDa 
polypeptides removed by urea treatment remained unaffected 
after mercury treatment. 
The effect of mercury was studied in more detail as a function 
of concentration. The polypeptide content for EP33, EP23 and 
EP16 following an incubation of 30 min, with various concen- 
trations of mercury is shown in Fig. 2 for PSII preparations 
isolated either from barley (Fig. 2A)or from spinach (Fig. 2B). 
At any mercury concentration, the polypeptide content in EP16 
and EP23 remained unaffected. However, EP33 is gradually 
released with increasing concentrations of mercury up to 10 
pM. Then, beyond these concentrations, the amount of pol- 
ypeptide released is less significant. There is no immediate ex- 
planation to this peculiar effect. A solubility problem would be 
doubtful considering that we are working in the tiM range, 
which is far below the solubility point of HgC12 (s = 6.9 g/100 
ml) [12]. Thus, there seem to be two contradictory effects of 
mercury at higher concentrations; one to remove EP33, another 
to maintain the polypeptide bound to the membrane. This 
could explain why we could not achieve the complete removal 
of EP33. The maximal removal was of 50% in PSII preparations 
isolated from barley. In spinach preparations, up to 60% of 
EP33 was removed. There is a more tenacious association of 
the EP33 in barley than in spinach. We observed the same 
phenomenon after urea treatment where 60% of EP33 was 
removed in barley, and 100% in spinach (results not shown). 
In Fig. 3, the depletion of EP33 is studied in PSII preparations 
already depleted in EP16 and EP24. It is shown that the absence 
of these two polypeptides did not significantly modify the ex- 
tent of depletion of EP33 nor the required Hg 2÷ concentration. 
In Fig. 4, the oxygen evolution activity is compared to the 
release of EP33 as a function of increasing concentrations of 
Hg(NO3) zfollowing a 5 min incubation. The decrease in activity 
seems to take place at much lower mercury concentrations than 
the release of the polypeptide. Moreover, at higher concentra- 
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Fig. 2. Polypeptide content of PSII preparations from barley (A) and 
spinach (B) as a function f mercury concentration: (e) EP33, (=) EP23, 
and (*) EP16. 
tions, EP33 is less removed while the activity still decreases. The 
same behavior was observed using HgC12 (data not shown). 
Thus, the effect of mercury on the polypeptide r moval and on 
oxygen evolution does not seem to be directly related. How- 
ever, there is probably aprimary effect of mercury which makes 
the oxygen evolving complex non-functional and provokes the 
depletion of EP33 and a secondary effect that prevents the 
release of the polypeptide from the membrane atHg 2+ concen- 
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Fig. 3. EP33 content of PSII preparations used either in their native 
form (©) or depleted in EP16 and EP23 before mercury treatments (e) 
as a function of mercury concentration. The maximal depletion (40%) 
is reached at 10 and 7.5/tM, respectively. 
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trations above 12 pM and delays this release at lower Hg 2+ 
concentrations even though oxygen evolution is inhibited. 
A relationship between inhibition and polypeptide pletion is 
supported by the action of C1- on the depletion of EP33 by Hg 2+ 
(Fig. 5). The depletion is strongly reduced in the presence of C1- 
during the incubation period. This anion is known to specifi- 
cally decrease the inhibitory effect of Hg 2+ on oxygen evolution 
[21. 
4. Discussion 
The data presented above clearly demonstrate hat EP33 can 
be removed by micromolar concentrations of Hg 2÷ without he 
removal of the two closely related extrinsic polypeptides of 16 
and 23 kDa and that EP16 and EP23 do not even retard the 
depletion of EP33 (Figs. 1-3). Usual treatments hat cause the 
release of EP33 produce the concomitant depletion of the EP16 
and EP23 (see [3,4] for reviews). This is mostly interpreted as 
an indication that EP33 is in closer proximity of the intrinsic 
protein components of PSII than EP23 and EP16. In fact, 
reconstitution experiments demonstrated that the presence of 
EP33 is essential for a high-affinity and stoichiometric binding 
of the EP23 polypeptide, and that EP33 and EP23 are essential 
for the proper binding of EP 16 [ 13-17]. Immunological studies 
[18] and cross-linking studies [19] have also suggested that the 
EP23 polypeptide binds to EP33. These results have been used 
to suggest that the extrinsic proteins bind to PSII in a particular 
sequence, EP33 binding to intrinsic protein component(s), 
EP23 binding to EP33 and EP16 to EP23. The present data 
seems to contradict the above interpretation, suggesting that 
the binding of EP23 and EP16 to PSII is independent from 
EP33. Along these lines, Yamamoto [20] suggested from phase 
partioning studies, that the three extrinsic proteins possess 
binding sites on some intrinsic components of PSII. Further- 
more, Larsson et al. [21] have also shown, on the basis of 
immunological studies, that EP23 binds to an intrinsic protein 
of PSII. 
Even though the reconstitution studies quoted above indi- 
cated an interaction between EP33, EP23 and EP16, Miyao and 
Murata [15] observed from sedimentation experiments hat in 
solution the three polypeptides cannot bind to each other. They 
proposed that the binding of EP33 to some intrinsic compo- 
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Fig. 4. Oxygen evolution (e) and EP33 content (©) of PSII preparations 
as a function of mercury concentration. 
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Fig. 5. Gel electrophoresis pattern of PSII preparations showing the 
effect of C1- on EP33 depletion. Lane 1, control PSII; lane 2, HgC12- 
treated PSII; lane 3, control PSII incubated with C1- (5 mM TMACL); 
lane 4, HgC12-treated PSII incubated with C1-. 
nent(s) induces a conformational change which allows subse- 
quent binding of EP23 to EP33 or to an intrinsic site on the 
membrane, and so on for 16 kDa. In the same way, Kavelaki 
and Ghanotakis [17] proposed that a direct interaction between 
33, 23, and 16 kDa polypeptides is the simplest model, but that 
a model where the EP33 is interacting with another protein 
which provides the binding sites for EP16 and EP23 cannot be 
excluded. Our results clearly support he second model: the fact 
that EP33 can be removed without affecting EP23 and EPI6 
(Figs. 1-3) is a direct demonstration of the existence of an 
intrinsic binding site for EP23. However, the possibility of in- 
teraction between EP23 and EP33 cannot be excluded, and 
probably this interaction isessential for optimal functioning of 
the oxygen evolving complex. 
It was previously shown that C1- prevents the inhibitory 
action of mercury [2]. The present study also demonstrates that 
this anion reduces the extent of EP33 depletion (Fig. 5). Thus, 
a possible mode of action that may be attributed to mercury 
inhibition is an interaction of Hg 2+ (micromolar concentration) 
at a site that modifies C1- binding [2] and produces the release 
of EP33. Mercury is known for its high affinity for sulfhydryl 
groups of proteins. EP33, EP23, and many intrinsic polypep- 
tides bear cysteins [22]. It will be important to evaluate if EP33 
itself or another protein is modified by mercury. Labelling 
assays hould clarify this question and should bring important 
information on the nature of the binding site(s) of EP33. 
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